Austarpharma   Report issue

For profit Phase 1
Founded: Edison NJ United States (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2020
NCT04536415
First Marketed Drug
2009
sertraline (zoloft)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AUSTARPHARMA | Austarpharma, LLC | AUSTARPHARMA LLC